Weekend Executive MBA
Rebecca Fish is the Vice President of Marketing and Product Strategy at Emergent BioSolutions. Emergent is a leader in the development of medical countermeasures, manufacturing products against biological and chemical threats including anthrax, smallpox, and botulism. The company also is involved in the development of products against emerging infectious diseases. Previously, Rebecca worked at GlaxoSmithKline in a variety of policy and marketing roles, including Global Head of Medical Countermeasures; Executive Director of Vaccine, Antibiotic, and Biodefense Policy; and Senior Director of Public Customer (CDC) Marketing. Rebecca also spent many years at Merck & Co. Inc., where she held a variety of sales and marketing positions. She was awarded a full scholarship to business school by the Merck Executive Team. Rebecca has managed approximately 1B USD in business for both Merck & Co., Inc. and GSK.
While Rebecca has worked in a variety of private sector roles, she also has spent significant time employed in the public sector. In her last role, Rebecca served as the Senior Policy Advisor to the Deputy Assistant Secretary of Health within the Department of Health and Human Services. She led the Vaccine Policy, Science, and Strategy team and led development of the U.S. National Adult Immunization Plan. She also has worked within the Centers for Medicare and Medicaid services developing new strategies for drug reimbursement policy and leading provider education efforts related to the Medicare Drug Card. Rebecca believes that her experience working in both the public and private sectors has been a valuable and unique opportunity that enables a broad perspective on the issues.
Rebecca graduated with a high honors degree in Psychobiology from Mount Holyoke College. She received her MBA from Duke University's Fuqua School of Business and currently serves as a member of Fuqua’s Health Care Alumni Advisory Board. She has completed a fellowship in biosecurity through the Johns Hopkins Center for Health Security and has published on a variety of topics, including global health security, vaccine policy, the public health emergency medical countermeasures enterprise (PHEMCE), and the Affordable Care Act. Rebecca is pursuing a PhD in Global Health Security/Biodefense with an emphasis on public and private sector collaboration as it relates to global health initiatives.